Publication | Open Access

Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies

New FamilyAlzheimer's DiseaseCholinesterase PathologiesBiochemistryMedicineNatural SciencesNeurochemical BiomarkersProtein MisfoldingAnti-alzheimer AgentsChemical BiologyPharmacologyDrug Discovery